Mr. Rob Hill reports

EMERALD HEALTH THERAPEUTICS ANNOUNCES COMPLETION OF PURE SUNFARMS CAD$20 MILLION CREDIT FACILITY WITH BANK OF MONTREAL AND FARM CREDIT CANADA

Emerald Health Therapeutics Inc.'s 50-per-cent-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms Corp., has entered into a credit agreement with Bank of Montreal as agent and lead lender and Farm Credit Canada (FCC) as lender in respect of a $20-million secured non-revolving term loan. Pure Sunfarms intends to use the funds available under the credit facility to finance the final costs of converting its 1.1-million-square-foot greenhouse for cannabis production, the vast majority of which was completed in January of this year. The funds available under the credit facility may also be used for general corporate purposes.

"Pure Sunfarms is proud to enter into this credit facility with these two highly respected institutional lenders," said Mandesh Dosanjh, president and chief executive officer, Pure Sunfarms. "This is truly an exciting time for our organization and we are appreciative of the support of each as Pure Sunfarms establishes itself as a vertically integrated supplier to the Canadian cannabis market."

"As Pure Sunfarms approaches operational positive cash flow, completion of a non-dilutive financing with these financial institutions is an excellent accomplishment," said Dr. Avtar Dhillon, president and executive chairman of Emerald. "We look forward to Pure Sunfarms' rapid quarterly growth through this year as it comes fully on stream."

The credit facility, which matures on Feb. 7, 2022, is secured by Pure Sunfarms' greenhouse facility, and contains customary financial and restrictive covenants.

With conversion of all growing areas, totalling more than one million square feet, of its greenhouse facility completed, Pure Sunfarms expects to be in production in all quadrants of the facility in the first quarter of this year. The technologically advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 16 grow rooms optimized for year-round harvesting (more than 80 harvests annually).

About Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics is a Canadian licensed producer of cannabis. Its 50-per-cent-owned Pure Sunfarms joint venture in British Columbia is completing the conversion of its 1.1-million-square-foot (25-acre) greenhouse for cannabis cultivation in the Lower Mainland and its Verdelite operation in Quebec is completing the buildout of its 75,000-square-foot indoor cultivation facility. Commercial production is expanding in both facilities.